Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Treating substance addiction: new insights and new approaches

Audience: Public Format: Hybrid
Add to my calendar

Professor Anne Lingford-Hughes presents in the Department of Psychiatry Seminar Series

Tuesday, 19 May 2026, 9.30am to 10.30am

Substance addiction continues to incur immense harm to physical and mental health to the individual as well to family, friends and wider society. Despite this, in the last few decades there have been very few new available treatments, indeed some medications are no longer available. This talk will describe the latest evidence from neuroimaging studies in addiction about key brain areas and neuromodulators that are informing development of new treatments. It will also describe some clinical trials using novel approaches. The talk will also describe the activities of the Addiction Healthcare Goals programme and opportunities for those interested in working in the field of addiction.

This seminar is hosted in person at the Department of Psychiatry. To join online, please use the link below:

https://zoom.us/[…]/94572787318?pwd=yQZc0eWXLehppqdtcdhbak2QTPy4V0.1
Meeting ID: 945 7278 7318
Passcode: 751629

Speaker(s): Professor Anne Lingford-Hughes (Imperial College London)

Series: Psychiatry Seminar Series

Venue: Department of Psychiatry - Seminar Room - Seminar Room Department of Psychiatry Headington Oxford Oxfordshire OX3 7JX United Kingdom

Department: Psychiatry (Department)

Organiser: Professor Andrea Cipriani

Host: Dr Riccardo De Giorgi

More info:

 

 

Professor Anne Lingford-Hughes is Professor of Addiction Biology and was Head, Division of Psychiatry at Imperial College London. She is also a Consultant Psychiatrist at Central North West London NHS Foundation Trust with a particular interest in pharmacological treatments of addiction. Prof Lingford-Hughes graduated in medicine from Oxford University, completed her PhD at Cambridge University, post-doc at NIMH and trained in psychiatry at The Bethlem and Maudsley Hospitals and Institute of Psychiatry, London. Her research has focused on using neuroimaging, pharmacological and behavioural challenges to characterize the neurobiology of addiction and clinical trials to improve relapse prevention. Prof Lingford-Hughes has contributed to national guidelines in addiction. She leads an MRC funded PhD programme (MARC) to produce future clinical addiction academic leaders in the UK. Prof Lingford-Hughes has been a member of several research panels eg MRC, Wellcome as well as on Boards/Councils of organisations such Academic Faculty of Royal College of Psychiatrists, British Association for Psychopharmacology and British Neuroscience Association. Prof Anne Lingford-Hughes is Chair, AddictionHealthcare Goal, Office for Life Sciences. The aim of the Goals programme is to make the UK a place where researchers and industry in addiction healthcare can thrive and partner effectively with NHS and Third Sector treatment providers to design, research and deploy innovative treatments and technologies which effectively tackle the challenges of drugand alcohol addictions, saving and improving the lives of those affected, and reducing the harms to the individual, their family and friends, and wider society.